REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 151 filers reported holding REVOLUTION MEDICINES INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,153,467 | -22.2% | 366,816 | -24.8% | 0.01% | -16.7% |
| Q2 2023 | $13,056,408 | +108894.1% | 488,090 | -11.7% | 0.01% | -14.3% |
| Q1 2023 | $11,979 | +136.2% | 553,051 | +159.8% | 0.01% | +133.3% |
| Q4 2022 | $5,071 | -100.0% | 212,904 | -65.7% | 0.00% | -62.5% |
| Q3 2022 | $12,245,000 | +145.9% | 620,925 | +143.1% | 0.01% | +166.7% |
| Q2 2022 | $4,979,000 | +721.6% | 255,443 | +974.5% | 0.00% | – |
| Q1 2022 | $606,000 | -35.2% | 23,773 | -36.0% | 0.00% | – |
| Q4 2021 | $935,000 | -81.8% | 37,149 | -80.1% | 0.00% | -100.0% |
| Q3 2021 | $5,144,000 | +287.6% | 186,971 | +347.1% | 0.00% | +200.0% |
| Q2 2021 | $1,327,000 | +58.2% | 41,820 | +128.6% | 0.00% | 0.0% |
| Q1 2021 | $839,000 | -88.6% | 18,295 | -90.2% | 0.00% | -80.0% |
| Q4 2020 | $7,381,000 | +2545.5% | 186,429 | +2012.0% | 0.01% | – |
| Q2 2020 | $279,000 | -88.5% | 8,827 | -92.0% | 0.00% | -100.0% |
| Q1 2020 | $2,416,000 | – | 110,289 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |